Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC)

PloS One
Andrew J PiperLeslie M Shaw

Abstract

The insulin-like growth factor-1 (IGF-1) signaling pathway has been implicated in non-small cell lung cancer (NSCLC) outcomes and resistance to targeted therapies. However, little is known regarding the molecular mechanisms by which this pathway contributes to the biology of NSCLC. The insulin receptor substrate (IRS) proteins are cytoplasmic adaptor proteins that signal downstream of the IGF-1R and determine the functional outcomes of this signaling pathway. In this study, we assessed the expression patterns of IRS-1 and IRS-2 in NSCLC to identify associations between IRS-1 and IRS-2 expression levels and survival outcomes in the two major histological subtypes of NSCLC, adenocarcinoma (ADC) and squamous cell carcinoma (SCC). High IRS-2 expression was significantly associated with decreased overall survival in adenocarcinoma (ADC) patients, whereas low IRS-1 cytoplasmic expression showed a trend toward association with decreased overall survival in squamous cell carcinoma (SCC) patients. Tumors with low IRS-1 and high IRS-2 expression were found to be associated with poor outcomes in ADC and SCC, indicating a potential role for IRS-2 in the aggressive behavior of NSCLC. Our results suggest distinct contributions of IRS-1 and I...Continue Reading

References

Dec 5, 2000·International Journal of Cancer. Journal International Du Cancer·B SchnarrD Mayer
Oct 29, 2004·Molecular and Cellular Biology·Julie A NagleLeslie M Shaw
Mar 1, 2005·Biochimie·Philippe GualJean-François Tanti
Aug 12, 2005·Nature·D Williams ParsonsVictor E Velculescu
Sep 21, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lisa M McShaneUNKNOWN Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics
Aug 3, 2006·Journal of Clinical Pathology·Diego SisciEva Surmacz
Oct 13, 2006·Molecular and Cellular Biology·Zhefu MaLeslie M Shaw
Mar 16, 2007·Cell Cycle·Shannon L GibsonLeslie M Shaw
Oct 25, 2008·Nature·Li DingRichard K Wilson
Nov 26, 2008·Nature Reviews. Cancer·Michael Pollak
Dec 6, 2008·The Journal of Biological Chemistry·Shannon L PankratzLeslie M Shaw
Dec 20, 2008·The American Journal of Pathology·Matthias SzabolcsRamon Parsons
Jun 19, 2009·Cell Communication and Signaling : CCS·Katerina MardilovichLeslie M Shaw
Sep 11, 2012·Nature·UNKNOWN Cancer Genome Atlas Research Network
Jan 25, 2014·International Journal of Cancer. Journal International Du Cancer·Kenichi SudaTetsuya Mitsudomi
Jul 25, 2014·Nature Reviews. Cancer·Zhao ChenKwok-Kin Wong
Aug 27, 2014·Frontiers in Oncology·Grzegorz J KorpantyNatasha B Leighl
Sep 1, 2014·Nature Medicine·Christine M LovlyWilliam Pao
Jul 15, 2015·Nature·Julie GeorgeRoman K Thomas
Jul 22, 2016·Proceedings of the National Academy of Sciences of the United States of America·Heather E MetzA McGarry Houghton
Sep 26, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Jun ZhaoYifei Chen
Oct 27, 2017·Nature Reviews. Cancer·Julia Rotow, Trever G Bivona

❮ Previous
Next ❯

Software Mentioned

Stata

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.